China Beijing SARS-CoV-2 Vaccines

China Beijing SARS-CoV-2 Vaccines

A view of China's first SARS-CoV-2 mRNA vaccine AWcorna, developed by Abogen Biosciences, Walvax Biotechnology, and the Academy of Military Medical Sciences' Institute of Biotechnology, displayed at the National 13th Five-Year Scientific and Technological Innovation Achievement Exhibition in Beijing, China Wednesday, Oct. 27, 2021. (FeatureChina via AP Images)

Use Information This content is intended for editorial use only.
For other uses, additional clearances may be required.

Use information: No Use in China

Contributor: FeatureChina

21301493345174
October 27, 2021 09:42:24 AM
October 28, 2021 01:42:34 PM
Uncredited
FCHNA
FeatureChina
For editorial use only. Please contact your AP representative for commercial use. China OUT.
4608 x 3456 2.23 MB
COVID-19 pandemic, Lung disease, Coronavirus, Diseases and conditions, Infectious diseases, Coronavirus, Health, Public health, Immunizations
BEIJING, CHINA
968640
CTR
zyf

This content is intended for editorial use only. For other uses, additional clearances may be required.

X

Message Box

Cancel
Ok
No
Yes